|
| |
 |
|
| ORIGINAL ARTICLE |
|
| Year : 2020 | Volume
: 10
| Issue : 7 | Page : 308-315 |
|
Ferruginol alleviates inflammation in dextran sulfate sodium-induced colitis in mice through inhibiting COX-2, MMP-9 and NF-κB signaling
Xiao-Yan Zhu1, Chun-Ling Zhang2, Yukiat Lin3, Min-Yan Dang3
1 Department of Gastroenterology, Jinan Central Hospital Affiliated to Shandong University, Jinan, 250013, Shandong Province, China
2 Department of Emergency, Taian City Central Hospital, Taian, 271000, Shandong Province, China
3 Innoscience Research Sdn Bhd, Subang Jaya, 47650, Selangor, Malaysia
| Date of Submission | 26-Jun-2019 |
| Date of Decision | 29-Aug-2019 |
| Date of Acceptance | 30-Jan-2020 |
| Date of Web Publication | 03-Jun-2020 |
Correspondence Address:
Min-Yan Dang
Innoscience Research Sdn Bhd, Subang Jaya, 47650, Selangor
Malaysia
 Source of Support: None, Conflict of Interest: None  | 2 |
DOI: 10.4103/2221-1691.284945
Objective: To assess the anti-inflammatory efficacy of ferruginol on dextran sulfate sodium (DSS) stimulated ulcerative colitis mice.
Methods: Ulcerative colitis was induced in C57BL/6J mice by administering 2% of DSS through drinking water for 7 d. The mice in the treatment group were treated with DAA+50 mg/kg/day ferruginol orally. In the positive control group, sulfasalazine (50 mg/kg/day) was used alongside with DSS. After induction, the bodyweight, character of stool and feces occult blood were recorded daily, the disease activity index was calculated, and the colon length, colon weight, and spleen weight were recorded. The myeloperoxidase activity was assayed by spectrophotometry. Interleukin (IL)-6, IL-1β, and tumor necrosis factor-a were determined by ELISA method, and nuclear factor-κB, cyclooxygenase-2, matrix metalloproteinases-9, and inducible nitric oxide synthase by Western blotting assays.
Results: Ferruginol significantly increased the bodyweight, colon weight, colon length, and decreased disease activity index and spleen weight. It exhibited anti-inflammatory activity against DSS induced ulcerative colitis in mice by reducing the activities of myeloperoxidase, tumor necrosis factor-α, nuclear factor-κβ, IL-1β, cyclooxygenase-2, matrix metalloproteinases-9, IL-6, and inducible nitric oxide synthase.
Conclusions: Ferruginol could be used to treat ulcerative colitis by attenuating the inflammation in colon cells and maintaining colonic mucosal barrier integrity.
Keywords: Ferruginol; Dextran sulfate sodium; Inflammation; Sulfasalazine; Ucerative colitis
How to cite this article:
Zhu XY, Zhang CL, Lin Y, Dang MY. Ferruginol alleviates inflammation in dextran sulfate sodium-induced colitis in mice through inhibiting COX-2, MMP-9 and NF-κB signaling. Asian Pac J Trop Biomed 2020;10:308-15 |
How to cite this URL:
Zhu XY, Zhang CL, Lin Y, Dang MY. Ferruginol alleviates inflammation in dextran sulfate sodium-induced colitis in mice through inhibiting COX-2, MMP-9 and NF-κB signaling. Asian Pac J Trop Biomed [serial online] 2020 [cited 2023 Mar 29];10:308-15. Available from: https://www.apjtb.org/text.asp?2020/10/7/308/284945 |
| 1. Introduction | |  |
It is known that the incidence of colorectal cancer is being increased every year, and the mortality rate is the second-highest worldwide[1]. Ulcerative colitis is an inflammatory bowel disease and is an important risk factor for developing colorectal cancer. Ulcerative colitis is characterized by severe stomach pain, diarrhea, bodyweight loss, and bleeding in colon (hematochezia) which rigorously worsen the quality of patients’ life[2].
Nuclear factor-κB (NF-κB) is an essential mediator of the inflammatory response and the NF-κB pathway is responsible to produce inflammatory cytokines that are important for the pathological process in chronic inflammatory diseases such as ulcerative colitis and gastric ulcers[3]. It is normally originated in the cytoplasm through the relative inhibitory proteins called NF-κB inhibitors (IκBS). Upon the activation, IκBS are phosphorylated with the IKB kinases complex that leads to the deprivation of IκB kinases. Consequently, the movement of NF-κB to the nucleus takes place, which stimulates inflammatory factors and additionally induces the transcription of inflammatory cytokines like inducible nitric oxide synthase (iNOS), cyclooxygenase (COX)-2, tumor necrosis factor-α (TNF-α), interleukin (IL)-1p, and IL-6[4],[5].
Nowadays, a variety of drugs are available for the treatment of ulcerative colitis including steroid hormone, 5-aminosalicylic acid, anti- TNF-α, and immunosuppressive agents. However, the uses are restricted because of the administration frequency, excessive cost, deleterious side effects and high prices[2]. More studies supported that natural compounds are effective in treating various cancers and inflammatory disorders[6]. Ferruginol (FGL) is an active phenolic compound with partial terpenoid structure (meroterpene) derived from the podocarpus andina (Podocarpaceae) and persea nubigena. Ferruginol exists in plants from the Verbenaceae, Podocarpaceae, Cupressaceae, and Lamiaceae families. FGL has antifungal, antibacterial[7], cardioprotective[8], miticidal[9], antioxidative[10], antiplasmodial[11], and antimalarial activity[12]. However, the anti-inflammatory effect of FGL on ulcerative colitis has not been completely studied. Hence, this investigation aimed to determine the anti-inflammatory mechanism of FGL in dextran sulfate sodium (DSS) induced ulcerative colitis mice.
| 2. Materials and Methods | | |
2.1. Chemicals and drugs
FGL, DSS, and sulfasalazine were obtained from Sigma Chemical Co (USA). Precise antibodies for iNOS, NF-κB p65, COX-2 and matrix metalloproteinases (MMP)-9, and β-actin were procured from Cell Signaling Technology (MA) and Santa Cruz Biotechnology (CA). The ELISA kits for IL-6, TNF-α, and IL-1β were purchased from R&D Systems Inc (Minneapolis). The other reagents and chemicals were of analytical grades.
2.2.Experimental animals
The animal experimentation procedures and handling were performed based on the experimental animal guidelines suggested by the International Animal Ethics Committee. The C57BL/6J mice (male breed) weighing about 26 g were fed with a typical laboratory diet with water ad libitum. Animals were maintained in controlled laboratory conditions [temperature: (22 ± 1) °C; humidity: 60%- 70%; light and dark cycle were 12 hours].
2.3. Induction and measurement of colitis in mice
Totally, 24 mice were used in this experiment and all mice were randomly divided into four groups with six animals in each. Mice in the normal control group had drinking water without DSS. For DSS- treated mice, the ulcerative colitis was induced by administering 2% of DSS orally through the drinking water[13]. The mice in the treatment group were treated with DAA+50 mg/kg/day of FGL orally. In the positive control group, sulfasalazine (50 mg/kg/day) was used alongside with DSS[23],[24]. On the 8th day of treatment, the animals were killed under anesthesia. The midline laparotomy technique was employed to open the abdominal cavity; then the whole colon tissue was taken and cut longitudinally for the morphological analysis. The colon and spleen tissues were taken and weighed.
2.4. Clinical activity scores
The bodyweight, character of stool and feces occult blood were recorded by a guaiac test (Hemoccult Sensa, CA) daily. The disease activity index (DAI) was calculated as follows: (a) percentage of bodyweight loss: 0% scored 0, 1%-5% scored 1, 6%-10% scored 2, 11%-15% scored 3, above 16% scored 4, (b) character of stool: normal as 0, loose stool as 1, diarrhea condition as 2; (c) feces occult blood: negative test result as 0, positive test result as 1, gross blood in stool as 2. The sum of all the mean scores was calculated as DAI[14].
2.5. Histopathological analysis
A piece of ulcerated colon tissue was taken, processed with neutral formalin solution (10%), fixed with paraffin wax and cut into the 5-μm slice. Then the slides were stained with hematoxylin & eosin and examined under a light microscope (Olympus, Shinjuku, Tokyo, Japan) to detect tissue damage such as the severity of ulceration, hemorrhage, mucosal damage and leucocytes infiltration[15].
2.6. Measurement of myeloperoxidase (MPO) enzyme activity
The colon tissues were mixed with the 10 × of phosphate buffer (pH-6.5) to reach 5% of homogenate. Then homogenized tissues were centrifuged at 14000 rpm for 30 min at 4 °C. Then 0.125 mL of supernatant was mixed with the 2.9 mL of reaction medium containing 0.16 mg/mL of o-dianisidine hydrochloride and 0.005% of hydrogen peroxide. It was incubated for 5 min, then the absorbance was read at 460 nm by using a spectrophotometer[16].
2.7. Determination of pro-inflammatory cytokines by ELISA method
The colon tissues were homogenized with the cell lysis buffer (pH-7.6). Then homogenate was centrifuged at 13 000 rpm for 25 min and the supernatant containing tissue lysates was collected for further estimations. The inflammatory cytokines level including IL- 1β, IL-6, and TNF-α were assayed by ELISA (manufacturers of R&D systems) based on manufacturer’s protocol.
2.8.Western blotting analysis
The colon tissue was cleaned thrice with saline buffer and homogenized with RIPA buffer containing the protease enzyme inhibitors for lysis. Then cell suspensions were centrifuged at 13 000 rpm for 20 min. After that, the supernatant was assayed by Lowry’s protein estimation method[17] and then by Western blotting analysis with the primary antibodies for iNOS, MMP-9, COX-2, NF-κB, and β-actin to determine the protein expression level. The ECL kit (Cell Signaling Tech, USA) was used to visualize the protein present in the membrane. The band was measured using enhanced chemiluminescence reagent kits (Santa Cruz Biotech, USA) and the intensity of the band was analyzed by ImageJ software.
2.9. Immunohistochemical analysis
For the immunohistochemical study of iNOS and COX-2 in the colon tissues, the paraffin-fixed sections in 5 μm thickness were processed by the method of Cha et al.[18]. The immunostained colon sections were observed under the electron microscope (Olympus, Shinjuku, Tokyo, Japan) at 40× magnification to detect the immune- subcellular complex.
2.10.Statistical analysis
The results were described as mean±standard deviation. The differences among the groups were analyzed with one-way analysis of variance (ANOVA) followed by Duncan multiple range test by SPSS (version 19). The significance level was set as α=0.05.
2.11. Ethical statement
All the experiments were approved by Institutional Ethical Committee (IAEC: JXCJCH20181011S72), Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong Province, China.
| 3. Results | | |
3.1. Effect of FGL on DAI score, bodyweight loss and character of stool
As compared to the normal control group, the significant bodyweight loss and increased DAI score were observed in DSS- treated mice (P <0.05). The DSS-treated mice exhibited diarrhea with bloody stool. After the treatment of FGL, the bodyweight was significantly increased, and the DAI score was significantly reduced, which was comparable to the effect of sulfasalazine. No mouse showed any diarrhea symptoms in the treatment groups [Figure 1]. | Figure 1: Effects of ferruginol on bodyweight (A) and disease activity index (DAI) (B).Values are given as mean ± SD for groups of 6 mice in each group. *P<0.01 when compared to the normal control, #P<0.01 when compared to the dextran sulfate sodium (DSS)-treated groups
Click here to view |
3.2. Effect of FGL treatment on the colon weight, colon length, and spleen enlargement
The colon weight and the length were significantly decreased, and spleen weight was significantly increased in the DSS-treated group compared to the normal group (P <0.05). After the treatment of FGL, the colon weight and the length were significantly increased, and the spleen weight was significantly decreased (P <0.05), which was comparable to the effect of sulfasalazine [Figure 2]A, [Figure 2]B, [Figure 2]C. | Figure 2: Effect of ferruginol on colon weight (A), colon length (B), and spleen weight (C). Values are given as mean ± SD for groups of 6 mice in each group. *P<0.05 when compared to the normal control, #P<0.05 when compared to the dextran sulfate sodium (DSS)-treated groups. SUL: sulfasalazine
Click here to view |
3.3. Effect of FGL treatment on histopathological changes
The histological results showed severe epithelial cell damage (ulceration) and infiltration of leucocytes in the mucosal area of DSS-treated mice. The FGL and sulfasalazine treatment attenuated the lesions in the mucosal area, reduced the penetration of inflammatory cells, and decreased ulcerative sores. On the whole, the FGL effectively attenuated histological changes in the mucosa and ulcerative lesions due to DSS administration [Figure 3]. | Figure 3: Effect of ferruginol on histological changes. Dextran sulfate sodium (DSS)-induced mice show ulceration and inflammatory cell filtration into the mucosa, which is restored by ferruginol and sulfasalazine. 200× magnification. The black arrow marks indicate epithelium damages, ulceration, and leucocyte infiltration.
Click here to view |
3.4. Effect of FGL treatment on MPO enzyme activity and level of the inflammatory cytokines
[Figure 4]A shows the significant elevation of MPO enzymatic activity in DSS-treated mice compared with the normal control mice (P <0.05). The treatment with FGL significantly decreased MPO activity compared with the DSS-treated group (P <0.01), which was comparable to the effect of sulfasalazine. | Figure 4: Effect of ferruginol on the myeloperoxidase (MPO) (A), tumor necrosis factor-α(TNF-α) (B), interleukin (IL)-6 (C), and IL-1β (D). Values are given as mean ± SD for groups of 6 mice in each group. *P<0.05 when compared to the normal control, #P<0.01 when compared to the dextran sulfate sodium (DSS)-treated groups.
Click here to view |
The significantly elevated levels of IL-6, TNF-α, and IL-1β were detected in DSS-treated mice compared with the normal control mice (P <0.05) [Figure 4]B, [Figure 4]C, [Figure 4]D. The treatment of FGL significantly decreased the levels of IL-1β, TNF-α, and IL-6 (P <0.05), which was comparable to the effect of sulfasalazine.
3.5. Effect of FGL on the expression of inflammatory cytokines by Western blotting analysis
There were significantly elevated expressions of iNOS, NF-κB p65, COX-2, and MMP-9 proteins in DSS-treated mice compared with normal control mice (P <0.05). The treatment of FGL significantly decreased the levels of iNOS, NF-κB p65, COX-2, and MMP-9 (P <0.05), which was comparable to the effect of sulfasalazine [Figure 5]. | Figure 5: Effect of ferruginol on nuclear factor-κB (NF-κB) p65, inducible nitric oxide synthase (iNOS), cyclooxygenase (COX)-2 and matrix metalloproteinases (MMP)-9. Values are given as mean ± SD for groups of 6 mice in each group. *P<0.05 versus the normal control, #P<0.05 versus the dextran sulfate sodium (DSS)-treated groups.
Click here to view |
3.6. Effect of FGL on immunohistochemical analysis of iNOS and COX-2
The protein expressions of iNOS and COX-2 were notably increased in DSS-treated mice compared with the normal control mice; while the expressions of iNOS and COX-2 were decreased in FGL administrated animals [Figure 6]. | Figure 6: Immunohistochemical analysis of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). The images at 40× magnification revealed that the ferruginol effectively diminished the expressions of iNOS (A) and COX-2 (B) in dextran sulfate sodium (DSS)-treated mice. Note: The expressions of iNOS and COX-2 expressions are indicated by arrows.
Click here to view |
| 4. Discussion | | |
DSS results in mucosal ulceration, diarrhea, bodyweight loss, bloody stool and shortened colonic length[19]. The decreased colon length and colon weight are the pathological and histological changes of ulcerative colitis, indicating the sternness of inflammatory bowel disease[20]. These symptoms including diarrhea and bloody stool are attributed to the penetration of abdominal cells to the lumen caused by DSS[21]. In our study, DSS-treated colitis mice displayed significant body weight loss, decreased colon length and colon weight, and higher DAI scores. Rajendiran et al.[22], Areche et al.[23] and Rodriguez et al.[24] all described the link between DAI scores and pathophysiological alterations of DSS-induced chronic and acute ulcerative colitis. Our findings showed that FGL administration could significantly increase the body weight, colon weight, colon length, and decrease DAI score.
MPO is a typical indicator of inflammatory condition, injury of tissues and penetration of neutrophils. The level of MPO in colonic tissues depends on the production of superoxide anion, which contributes to the mucosal dysfunction and tissue necrosis[25]. In this study, we observed the level of MPO was significantly elevated in DSS-treated animals, while it was significantly reduced after the FGL treatment, indicting the anti-inflammatory potential of FGL.
NF-κB is considered as an essential mediator of inflammatory cytokines. It is involved in the pathologic process of ulcerative colitis, colon cancer, and inflammatory bowel disease[26],[27], and can lead to the losing of colonic epithelial cells[28]. The research of Kasinathan et al.[26] noted the elevated expression of NF-κB in DSS administered animals, which proved the induction of inflammation. Our study also displayed increased NF-KκB p65 expression in DSS-treated mice and significantly decreased expressions after FGL treatment. The levels of pro-inflammatory cytokines namely TNF-α, IL-1β, and IL-6 are usually increased during the pathological process of colitis, and these inflammatory cytokines also regulate the initiation of colorectal cancer[29]. The previous study reported that the expression of IL-6, IL- 1β, and TNF-α was associated with NF-κB activation that regulates the inflammatory response and the duration of continual inflammation[30]. In this view, the suppression of these inflammatory cytokines like IL-6, TNF-α, and IL-1β would be a possible and efficient treatment of colon cancer[31]. Our study showed no NF-κB translocation to the nucleus in FGL treated colitis mice, which directly supported the finding of Rodriguez et al. [32] and proved the anti-inflammatory effect of FGL.
The COX-2 and iNOS are good indicators for colon cancer diagnosis in both in vitro and in vivo experiments[33]. In our work, we also observed elevated expression of COX-2 and iNOS in DSS administered colitis mice, which is similar to the findings of Umesalma and Sudhandiran[34]. The FGL treatment effectively attenuated the increased expression of iNOS and COX-2 as a gastroprotective agent[32]. Some studies described the overexpression of MMP-9 in the lesions of the healthy mucosa, which was considered as an important indicator for the early diagnosis of colorectal cancer[35]. It also described that the MMP-9 regulated the metastatic progression in colon carcinoma, expressed by macrophages, mast cells and neutrophils[36]. Our study showed that the treatment with FGL significantly prevented the increased MMP-9 expression in DSS-treated colitis mice. In addition, the histopathological assessment of colon tissues exhibited severe ulceration and infiltration of leucocytes in DSS-induced colitis mice. But, the FGL treatment effectively reversed and ameliorated the mucosal sores, reduced the penetration of the inflammatory cells and histological alterations in mucosa induced by DSS.
In conclusion, the findings of this work proved that the administration of FGL efficiently inhibited the DSS-induced ulcerative colitis in mice and also ameliorated the severe inflammation by preventing the NF- B pathway in colon cells. Besides, the effect of FGL is comparable with sulfasalazine. FGL could be an effective herbal-based compound for treating ulcerative colitis.
Conflict of interest statement
We declare that there is no conflict of interest.
Authors’ contributions
The original ideas, formulation of this research goals and aims were performed by MYD and CLZ. The verification of research data and the overall experimental results were performed by XYZ and YL. The manuscript was originally written by the XYZ, and review, editing and proof reading were performed by MYD, CLZ, and XYZ.
| References | | |
| 1. | Park JH, McMillan DC, Horgan PG, Roxburgh CS. The impact of antiinflammatory agents on the outcome of patients with colorectal cancer. Cancer Treat Rev 2014; 40: 68-77.  |
| 2. | Yu XT, Xu YF, Huang YF, Qu C, Xu LQ, Su ZR, et al. Berberrubine attenuates mucosal lesions and inflammation in dextran sodium sulfate- induced colitis in mice. PLoS One; 2018; 13: e0194069. |
| 3. | Chae HS, You BH, Song J, Ko HW, Choi YH, Chin YW. Mangosteen extract prevents dextran sulfate sodium-induced colitis in mice by suppressing NF-κB activation and inflammation. J Med Food 2017; 20: 727-733. |
| 4. | Hayden MS, West AP, Ghosh S. NF-kappa B and the immune response. Oncogene 2006; 25: 6758-6780. |
| 5. | Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, et al. Molecular mechanisms underlying chemopreventive activities of anti- inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res 2001; 480-481: 243-268. |
| 6. | Aggarwal BB, Ichikawa H, Garodia P, Weerasinghe P, Sethi G, Bhatt ID, et al. From traditional Ayurvedic medicine to modern medicine: Identification of therapeutic targets for suppression of inflammation and cancer. Expert Opin Ther Targets 2006; 10: 87-118. |
| 7. | Bufalo J, Cantrell CL, Jacob MR, Schrader KK, Tekwani BL, Kustova TS, et al. Antimicrobial and antileishmanial activities of diterpenoids isolated from the roots of Salvia deserta. Planta Med 2016; 82: 131-137. |
| 8. | Ulubelen A, Birman H, Oksuz S, Top^u G, Kolak U, Barla A, et al. Cardioactive diterpenes from the roots of Salvia eriophora. Planta Med 2002; 68: 818-821. |
| 9. | Chang ST, Chen PF, Wang SY, Wu HH. Antimite activity of essential oils and their constituents from Taiwania cryptomerioides. J Med Entomol 2001; 38: 455-457. |
| 10. | Roa-Linares VC, Brand YM, Agudelo-Gomez LS, Tangarife-Castano V, Betancur-Galvis LA, Gallego-Gomez JC, et al. Anti-herpetic and anti-dengue activity of abietane ferruginol analogues synthesized from (+)-dehydroabietylamine. Eur J Med Chem 2016; 108: 79-88. |
| 11. | Areche C, Theoduloz C, Yanez T, Souza-Brito AR, Barbastefano V, de Paula D, et al. Gastroprotective activity of ferruginolin mice and rats: Effects on gastric secretion, endogenous prostaglandins and non-protein sulfhydryls. J Pharm Pharmacol 2008; 60: 245-251. |
| 12. | Gonzalez MA, Clark J, Connelly M, Rivas F. Antimalarial activity of abietane ferruginol analogues possessing a phthalimide group. Bioorg Med Chem Lett 2014; 24: 5234-5237. |
| 13. | Ma J, Yin G, Lu Z, Xie P, Zhou H, Liu J, et al. Casticin prevents DSS induced ulcerative colitis in mice through inhibitions of NF-κB pathway and ROS signaling. Phytother Res 2018; 32(9): 1770-1783. |
| 14. | Xu J, Yu P, Wu L, Liu M, Lu Y. Effect of Trichinella spiralis intervention on TNBS-induced experimental colitis in mice. Immunobiology 2019; 224(1): 147-153. |
| 15. | Katakura K, Lee J, Rachmilewitz D, Li G, Eckmann L, Raz E. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 2005; 115: 695-702. |
| 16. | Islam MS, Murata T, Fujisawa M, Nagasaka R, Ushio H, Bari AM, et al. Anti-inflammatory effects of phytosteryl ferulates in colitis induced by dextran sulphate sodium in mice. Br J Pharmacol 2008; 154: 812-824. |
| 17. | Lowry OH, Rosebrough MJ, Farr AL, Randall RJ. Protein measurement with Folin-phenol reagent. J Biol Chem 1951; 193: 265-275. |
| 18. | Cha JH, Woo SK, Han KH, Kim YH, Handler JS, Kim J, et al. Hydration status affects nuclear distribution of transcription factor tonicity responsive enhancer binding protein in rat kidney. J Am Soc Nephrol 2001; 12: 2221-2230. |
| 19. | Wirtz S, Neurath MF. Mouse models of inflammatory bowel disease. Adv Drug Deliv Rev 2007; 59: 1073-1083. |
| 20. | Solomon L, Mansor S, Mallon P, Donnelly E, Hoper M, Loughrey M, et al. The dextran sulphate sodium (DSS) model of colitis: An overview. Comp Clin Path 2010; 19: 235-239. |
| 21. | Yan Y, Kolachala V, Dalmasso G, Nguyen H, Laroui H, Sitaraman SV, et al. Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS One 2009; 4: e6073. |
| 22. | Rajendiran V, Natarajan V, Devaraj SN. Anti-inflammatory activity of Alpinia officinarum Hance on rat colon inflammation and tissue damage in DSS induced acute and chronic colitis models. Food Sci Human Wellness 2018; 7: 273-281. |
| 23. | Areche C, Theoduloz C, Yanez T, Souza-Brito ARM, Barbastefano V, de Paula D, et al. Gastroprotective activity of ferruginol in mice and rats: Effects on gastric secretion, endogenous prostaglandins and non-protein sulfhydryls. J Pharm Pharmacol 2008; 60(2): 245-251. |
| 24. | Rodriguez JA, Theoduloz C, Yanez T, Becerra J, Schmeda-Hirschmann G. Gastroprotective and ulcer healing effect of ferruginol in mice and rats: Assessment of its mechanism of action using in vitro models. Life Sci 2006; 78(21): 2503-2509. |
| 25. | Han F, Zhang H, Xia X, Xiong H, Song D, Zong X, et al. Porcine p-defensin 2 attenuates inflammation and mucosal lesions in dextran sodium sulfate-induced colitis. J Immunol 2015; 194: 1882-1893. |
| 26. | Kasinathan NK, Subramaniya B, Sivasithamparam ND. NF-κB/twist mediated regulation of colonic inflammation by lupeol in abating dextran sodium sulfate induced colitis in mice. J Funct Foods 2018; 41: 240-249. |
| 27. | Sanchez-Fidalgo S, Cardeno A, Sanchez-Hidalgo M, Aparicio-Soto M, de la Lastra CA. Dietary extra virgin olive oil polyphenols supplementation modulates DSS-induced chronic colitis in mice. J Nutr Biochem 2013; 24: 1401-1413. |
| 28. | Yang L, Shen L, Li Y, Li Y, Yu S, Wang S. Hyperoside attenuates dextran sulfate sodium-induced colitis in mice possibly via activation of the Nrf2 signalling pathway. J Inflamm (Lond) 2017; 14: 25. |
| 29. | Lee SJ, Lim KT. Inhibitory effect of phytoglycoprotein on tumor necrosis factor-alpha and interleukin-6 at initiation stage of colon cancer in 1,2- dimethylhydrazine-treated ICR mice. Toxicol Appl Pharmacol 2007; 225: 198-205. |
| 30. | Azzolina A, Bongiovanni A, Lampiasi N. Substance P induces TNF- alpha and IL-6 production through NF kappa B in peritoneal mast cells. Biochim Biophys Acta 2003; 1643: 75-83. |
| 31. | vanGrevenstein WM, Hofland LJ, van Rossen ME, van Koetsveld PM, Jeekel J, van Eijck CH. Inflammatory cytokines stimulate the adhesion of colon carcinoma cells to mesothelial monolayers. Dig Dis Sci 2007; 52: 2775-2783. |
| 32. | Rodnguez JA, Theoduloz C, Yanez T, Becerra J, Schmeda-Hirschmann G. Gastroprotective and ulcer healing effect of ferruginol in mice and rats: Assessment of its mechanism of action using in vitro models. Life Sci 2006; 78: 2503-2509. |
| 33. | Takahashi M, Mutoh M, Kawamori T, Sugimura T, Wakabayashi K. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. Carcinogenesis 2000; 21: 1319-1327. |
| 34. | Umesalma S, Sudhandiran G. Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-kappa B, iNOS, COX-2, TNF-alpha, and IL-6 in 1,2-dimethylhydrazine-induced rat colon carcinogenesis. Basic Clin Pharmacol Toxicol 2010; 107: 650-655. |
| 35. | Otero-Estevez O, De Chiara L, Rodnguez-Girondo M, Rodnguez- Berrocal FJ, Cubiella J, Castro I, et al. Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening. Sci Rep 2015; 5: 13030. |
| 36. | Garg P, Sarma D, Jeppsson S, Patel NR, Gewirtz AT, Merlin D, Sitaraman SV. Matrix metalloproteinase-9 functions as a tumor suppressor in colitis- associated cancer. Cancer Res 2010; 70: 792-801. |
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6]
| This article has been cited by | | 1 |
Natural Products with Tandem Anti-inflammatory, Immunomodulatory
and Anti-SARS-CoV/2 Effects: A Drug Discovery Perspective
against SARS-CoV-2 |
|
| Luana N.O. Leal da Cunha, Tiago Tizziani, Gabriella B. Souza, Monalisa A. Moreira, José S.S. Neto, Carlos V.D. dos Santos, Maryelle G. de Carvalho, Eduardo M. Dalmarco, Leonardo B. Turqueti, Marcus Tullius Scotti, Luciana Scotti, Francisco F. de Assis, Antonio Luiz Braga, Louis Pergaud Sandjo | | Current Medicinal Chemistry. 2022; 29(14): 2530 | | [Pubmed] | [DOI] | | | 2 |
Possible Use of Phytochemicals for Recovery from COVID-19-Induced Anosmia and Ageusia |
|
| Sachiko Koyama,Kenji Kondo,Rumi Ueha,Hideki Kashiwadani,Thomas Heinbockel | | International Journal of Molecular Sciences. 2021; 22(16): 8912 | | [Pubmed] | [DOI] | |
|
 |
|
|
|
Search Pubmed for